Pure Global AI
NCT05976191Recruiting

Comparison of Fasting Blood Glucose Measurements From Fingertip and Intravenous on Patient Satisfaction in Patients With Diabetes Mellitus

Istanbul University Cerrahpaşa-IUC
Istanbul University - Cerrahpasa (IUC)ClinicalTrials.govbehavioral
Study focus
Disease/Condition
Diabetes Mellitus
Drug/Device/Intervention
Patients whose blood glucose is measured intravenously and from the fingertip
Study type
Interventional
Intervention type
behavioral
Sponsor & location
Primary sponsor
Istanbul University - Cerrahpasa (IUC)
Location
Istanbul,Istanbul, Turkey
Timeline & enrollment
Phase
N/A
Start date
Mar 01, 2023
End date
Sep 30, 2023
Enrollment
110 participants
Primary outcome

Blood Glucose Measurement Patient Satisfaction Form

Summary

The study was designed as a randomized controlled experimental study in order to compare the
 fasting blood glucose values measured by puncturing the fingertips and using the intravenous
 route of patients diagnosed with diabetes mellitus, and to determine the effect on patient
 satisfaction. The blood glucose measurement via the intravenous catheter has an effect on
 increasing the comfort of the patient compared to the fingertip measurement. It is thought
 that information can be provided to increase patient satisfaction.

ICD-10 classifications
Diabetes mellitusUnspecified diabetes mellitusOther specified diabetes mellitusUnspecified diabetes mellitus without complicationsUnspecified diabetes mellitus with unspecified complications
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT05976191
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT05976191 through Pure Global AI's free database. This phase not specified trial is sponsored by Istanbul University - Cerrahpasa (IUC) and is currently Recruiting. The study focuses on Diabetes Mellitus. Target enrollment is 110 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.